Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EU Agency Recommends Sanofi SA, Merck KGaA Pediatric Vaccine-Reuters


Friday, 22 Feb 2013 07:10am EST 

Reuters reported that the European Medicines Agency recommended approval of Hexyon, a new 6-in-1 pediatric vaccine from Sanofi Pasteur MSD, a joint venture between Merck KGaA and Sanofi SA. The new vaccine protects against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis and invasive infections caused by Haemophilus influenzae type b. Recommendations for marketing approval by the EMA's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months. 

Company Quote

65.34
1.06 +1.65%
11:12am EDT